Clinical Trial Update: A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1b study evaluating GS-9820 in subjects with lymphoid malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Malignancies

Drugs mentioned

• GS-9820

Snippet

Sponsor: Gilead Sciences | Conditions: Lymphoid Malignancies | Phase 1 | Status: COMPLETED